SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Ronald Reagan — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientRonald Reagan
Date of birth1911-02-06
IdentifiersMRN HR-ML008-SYN-TD; SSN (made up) 000-08-6047
Document date2001-02-24
AuthorMargaret Ellison, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week post-fracture check, with neurology consultation for dementia staging and evening restlessness. [S]

History of Present Illness

Mr. Reagan is a 90-year-old man with moderate Alzheimer's disease who returns two weeks after his first visit following repair of a right hip fracture, and is seen by neurology on the same day. Oxycodone and diphenhydramine were stopped two weeks ago. His hip aches a little when he walks, and scheduled acetaminophen keeps him comfortable. His caregivers report that he sleeps as well as before without the diphenhydramine and has been no more confused. He finished 35 days of enoxaparin last week, without bruising or bleeding. Home physical therapy continues, and he walks short distances in the house with a front-wheeled walker and standby help. He has had no falls. Grab bars, a raised toilet seat, and night lights went in after the home safety assessment, and loose rugs were taken up. Mild evening restlessness and repeated questions continue; a quiet, unhurried evening routine settles them. He takes donepezil each morning and vitamin D daily from a weekly organizer. [S]

ElementDetail
Interval changeMild hip ache on walking; walking a little farther with the walker
Medicines stopped two weeks agoOxycodone and diphenhydramine; no worse sleep or confusion since
Clot preventionEnoxaparin finished at day 35 last week; no bleeding
FallsNone
BehaviorMild evening restlessness and repeated questions, settled by routine
FunctionBarthel Index 60, up from 55 two weeks ago

Review of Systems

SystemResultFinding
ConstitutionalNegativeAppetite good; no fever
CardiovascularNegativeNo lightheadedness on standing, fainting, or calf swelling
GastrointestinalNegativeNo constipation since oxycodone was stopped; no nausea on donepezil
MusculoskeletalPositiveMild right hip ache on walking, eased by acetaminophen
NeurologicalPositiveKnown memory loss, unchanged by his caregivers' account; no new weakness
PsychiatricPositiveMild evening restlessness; no hallucinations, aggression, or low mood

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Donepezil 10 mg oral tablet, one tablet by mouth daily in the morningOne tablet by mouth daily in the morningOral route1997-03-07activeS
Acetaminophen 500 mg oral tablet, two tablets (1,000 mg) by mouth three times dailyTwo tablets by mouth three times dailyOral route2001-01-14 to 2001-04-14completedS
Oxycodone 5 mg oral tablet, one tablet by mouth every six hours as needed for severe painOne tablet by mouth every six hours as needed for severe painOral route2001-01-14 to 2001-02-10stoppedS
Diphenhydramine 25 mg oral capsule, one capsule by mouth at bedtimeOne capsule by mouth at bedtimeOral route2001-01-16 to 2001-02-10stoppedS
Enoxaparin 40 mg/0.4 mL prefilled syringe, inject 40 mg under the skin daily through day 35 after surgeryInject 40 mg under the skin once dailySubcutaneous route2001-01-14 to 2001-02-17completedS
Cholecalciferol 50 mcg (2,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2001-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2001-02-24Body height185cmS
2001-02-24Body weight76.5kgS
2001-02-24Body mass index (BMI) [Ratio]22.4kg/m2S
2001-02-24Systolic blood pressure126mm[Hg]S
2001-02-24Diastolic blood pressure72mm[Hg]S
2001-02-24Heart rate62/minS
2001-02-24Respiratory rate16/minS
2001-02-24Body temperature36.7CelS
2001-02-24Oxygen saturation in Arterial blood by Pulse oximetry96%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2001-02-24Total score Barthel Index60{score}S

Physical Exam

Vital signs recorded on 2001-02-24; see the Vital Signs section. [S]

SystemFinding
GeneralAlert, pleasant, and sociable
CardiovascularRegular rhythm at 62 per minute; no murmur; no ankle edema
MusculoskeletalRight hip incision healed; no calf tenderness or swelling; stands with arm help and walks with a front-wheeled walker and standby help, steady
NeurologicalOriented to person, not to date; follows one-step commands; no focal weakness
PsychiatricCheerful; no agitation during the visit

Problems

ProblemClinical statusVerificationCodeProvenance
Alzheimer's disease with late onset, disclosed in 1969activeconfirmed G30.1S — Synthetic modern coding of the publicly disclosed diagnosis.
Dementia due to Alzheimer's disease, moderate (FAST stage 5), with evening restlessnessactiveconfirmed F02.B0S — Synthetic stage; his actual stage at this age was not made public.
Osteoporosis with right hip fragility fracture after a fall at home, repaired with internal fixation; subsequent careactiveconfirmed M80.051DS — Synthetic modern coding of the documented January 2001 hip fracture as an osteoporotic fracture; bone density and fracture pattern are synthetic.
Vitamin D deficiencyresolvedconfirmed E55.9S — Synthetic finding from the first-visit 25-hydroxyvitamin D; repleted by three months.
Acute blood loss anemia after hip surgeryresolvedconfirmed D62S — Synthetic postoperative finding; resolved by three months.
History of fallingactiveconfirmed Z91.81S — Synthetic modern coding linked to the documented fall.
Personal history of colon cancer, operated on in 1960activeconfirmed Z85.038S — Synthetic modern coding of the documented 1985 operation.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationPain assessmentEvery visitCompleted todayMild hip ache on walking; scheduled acetaminophen only; no opioid since the first visit
ExaminationPhysical and occupational therapy progressEvery visitCompleted todayBarthel Index 60, up from 55; home therapy continues
ExaminationCDC STEADI fall-risk screen: fall history, gait and balance, postural blood pressureEvery primary care visit after the fractureCompleted todayNo falls; steady with the walker and standby help; no lightheadedness on standing
ExaminationTimed Up and GoWhen home therapy ends, then yearly or with a changeUp to date24 seconds two weeks ago; repeat when home therapy ends
ExaminationHome safety evaluationAt diagnosis and each follow-upCompleted todayGrab bars, raised toilet seat, and night lights installed; rugs removed
ExaminationDriving safetyAt diagnosis and yearlyNot indicatedHis caregivers provide all transport
Medication safetyVenous thromboembolism prophylaxisAt least 10 to 14 days, up to 35 days after surgeryCompleted todayEnoxaparin finished at day 35 last week; no bleeding or calf swelling
Medication safetyAGS Beers Criteria medication reviewEvery visit and at each transition of careCompleted todayNo opioid, antihistamine, or sedative since the first visit
Medication safetyCholinesterase inhibitor benefit and tolerabilityEach follow-upCompleted todayDonepezil continued: heart rate 62, no fainting, nausea, or weight loss
Medication safetyAntipsychotic appropriateness reviewEvery visit while on an antipsychoticNot indicatedNot on an antipsychotic; neurology advises none
SurveyNeuropsychiatric symptom screen (NPI-Q)Every visitCompleted todayMild evening restlessness and repeated questions; no hallucinations or aggression
SurveyCognitive test (MoCA), FAST stage, and ADL and IADL scoresAt diagnosis, then yearlyCompleted todayNeurology confirms FAST stage 5. MoCA 11 of 30, Barthel Index 55, and Lawton IADL 1 of 8 at the first visit two weeks ago; next full set in a year
SurveyDepression screen (GDS-15)At 1, 3, and 6 months after the fracture; yearly in dementiaUp to dateGDS-15 4 at the one-month visit two weeks ago; next at three months
SurveyCaregiver assessment with the Zarit Burden InterviewAt diagnosis, then every 6 to 12 monthsUp to date41 of 88 two weeks ago; repeat at six months
LaboratoryTSH and vitamin B12At the diagnosis of dementia; repeat only as indicatedNot indicatedThe dementia workup belongs to the original diagnosis years ago; TSH was normal two weeks ago
ImagingBrain MRIOnce at diagnosis; repeat only with an acute changeNot indicatedNo new neurologic signs
LaboratoryAPOE genotype, amyloid biomarkers, and baseline MRI for anti-amyloid therapyBefore starting lecanemab or donanemabNot indicatedModerate dementia (MoCA 11) is outside the eligibility range for anti-amyloid therapy
Laboratory25-hydroxyvitamin D after repletionRepeat after repletionDue16 ng/mL two weeks ago; recheck at three months before zoledronic acid
ImagingDXA after the fractureAt the first outpatient visit if not previously diagnosedDueNot obtained at the first visit; by plan it is done at the three-month visit with the first infusion, after vitamin D repletion, so treatment is not delayed
ReferralFracture Liaison ServiceDuring the hospital stay, with follow-up for a yearDeferredNo fracture liaison referral is on record from the hospital stay, a deviation from the protocol. Primary care is carrying out the same steps (vitamin D repletion, DXA, and zoledronic acid at three months) and tracks them here, so no step has been lost
ReferralNeurology consultationAt stage changes or when behavior changesCompleted todaySeen today for staging, donepezil review, and evening restlessness
ReferralCaregiver support servicesOngoingCompleted todayHome health aide in place; weekly respite and Alzheimer's Association support services arranged
Self-managementAdvance care planningAt diagnosis, yearly, and at stage changesCompleted todayHealth care agent confirmed and goals of care discussed; POLST form at the three-month visit
Self-managementCalcium intake from food and supplementsOngoing; target 1,000 to 1,200 mg a dayCompleted todayReviewed with his caregivers; calcium-rich food at each meal

Goal progress:

Guideline basis: Management of Hip Fractures in Older Adults Evidence-Based Clinical Practice Guideline (2021); The clinician's guide to prevention and treatment of osteoporosis (2022); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD) (2024); CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, hip/pelvic fracture, and osteoporosis monographs (2026)

Follow-up: Three-month post-fracture visit in seven weeks, with DXA, laboratory tests, and zoledronic acid if they allow. Next scheduled visit 2001-04-14: three-month post-fracture visit with bone density testing and zoledronic acid. [S]